The abstract is read at the publisher; the summary is JClub's.
A Viewpoint proposes five principles to judge when genomic therapy is a viable treatment option, aiming to support durable genomic interventions.
- Why it matters: The field needs a practical framework to decide when genomic therapy is appropriate, addressing uncertainty about durability and clinical readiness.
- What they did: The authors review recent genomic therapy advances and lay out five guiding principles for evaluating viability as a treatment option.
- The result: The proposed principles provide a structured way to assess genomic interventions’ durability, helping clinicians consider genomic therapy more consistently.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.